New biomarker for diagnosis of Alzheimer’s disease


New biomarker for diagnosis of Alzheimer’s disease

  • November 12, 2019

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder leading to memory loss and progressive cognitive decline, and a worsening problem worldwide affecting 50 million people in 2018 and projected to triple by 2050. 

iHealthtech PI Asst Prof John Chua and his group has identified novel early biomarkers for Alzheimer’s disease, in particular Hebp1 which is involved in the death of brain cells when blood is leaked from damaged blood vessels in the brain. 

“These discoveries could potentially lead to earlier diagnoses of AD and improve management of the disease, including the possibility of slowing the progression of neuronal damage and the patient’s manifestations of cognitive impairment. This would mean that patients would be able to have a better quality of life despite the diagnosis,” said Asst Prof Chua. 

Please click the link below for the research article: 

Please click the links below for the news articles: